XML 32 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenues $ 33,208,060 $ 13,461,504 $ 90,420,280 $ 30,537,829
Cost of revenues 15,027,521 4,781,677 39,647,473 10,831,763
Gross profit 18,180,539 8,679,827 50,772,807 19,706,066
Operating expenses:        
Personnel 1,481,350 1,354,644 5,266,745 4,075,168
Marketing and promotion 563,193 103,327 1,057,892 281,329
General and administrative 9,481,030 2,931,684 16,933,758 7,515,721
Bad debts 35,583 892,029 1,854,869 1,342,029
Total operating expenses 11,561,156 5,281,684 25,113,264 13,214,247
Operating income 6,619,383 3,398,143 25,659,543 6,491,819
Non-operating income (expenses):        
Interest expense (299,969) (1,921,312) (2,076,587) (7,581,648)
Interest income 25,739 34,818 95,534 121,712
Loss on obligations settled with equity (2,546) (44,678)
Equity in earnings of investments 51,511 18,553
Change in fair value of investments (522,106) 217,374 (937,390) (704,172)
Other 309,212 (84,708) 309,212 (84,708)
Total non-operating income (expenses), net (487,124) (1,702,317) (2,611,777) (8,274,941)
Income (loss) before income taxes 6,132,259 1,695,826 23,047,766 (1,783,122)
Provision for income taxes 4,009,111 9,026,016
Net income (loss) 2,123,148 1,695,826 14,021,750 (1,783,122)
Net income (loss) attributable to noncontrolling interests 103,113 36,959 288,960 193,492
Net income (loss) attributable to MariMed Inc. $ 2,020,035 $ 1,658,867 $ 13,732,790 $ (1,976,614)
Net income (loss) per share        
Basic $ 0.01 $ 0.01 $ 0.04 $ (0.01)
Diluted $ 0.01 $ 0.00 $ 0.04 $ (0.01)
Weighted average common shares outstanding        
Basic 329,454,104 281,535,212 324,340,006 254,387,761
Diluted 378,934,045 346,091,840 370,203,937 254,387,761